Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2019
Summary Of Significant Accounting Policies [Line Items]
Freezing amount in cash resulted from court pending legal action issued				$ 0.5
Advertising costs	$ 0.5	$ 0.5	$ 0.9
Musculoskeletal Transplant Foundation ("MTF") [Member]
Summary Of Significant Accounting Policies [Line Items]
Expenditures for other research and development	0.0	0.8	0.8
Neo Medical SA [Member]
Summary Of Significant Accounting Policies [Line Items]
Expenditures for other research and development	0.5	0.6
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Transactional foreign currency gains and (losses), including those generated from intercompany operations	$ (3.3)	$ (4.0)	3.9
Maximum [Member] | Neo Medical SA [Member]
Summary Of Significant Accounting Policies [Line Items]
Expenditures for other research and development			$ 0.1